RT Journal Article
SR Electronic
T1 Age disparities in lung cancer survival in New Zealand: the role of patient and clinical factors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.05.20206912
DO 10.1101/2020.10.05.20206912
A1 Sophie Pilleron
A1 Camille Maringe
A1 Hadrien Charvat
A1 June Atkinson
A1 Eva Morris
A1 Diana Sarfati
YR 2020
UL http://medrxiv.org/content/early/2020/10/06/2020.10.05.20206912.abstract
AB Background Age is an important prognostic factor for lung cancer. However, no studies have investigated the age difference in lung cancer survival per se. We, therefore, described the role of patient-related and clinical factors on the age pattern in lung cancer excess mortality hazard by stage at diagnosis in New Zealand.Methods We extracted 22 487 new lung cancer cases aged 50-99 (median age = 71, 47.1% females) diagnosed between 1 January 2006 and 31 July 2017 from the New Zealand population-based cancer registry and followed up to December 2019. We modelled the effect of age at diagnosis, sex, ethnicity, deprivation, comorbidity, and emergency presentation on the excess mortality hazard by stage at diagnosis, and we derived corresponding lung cancer net survival.Results The age difference in net survival was particularly marked for localised and regional lung cancers, with a sharp decline in survival from the age of 70. No identified factors influenced age disparities in patients with localised cancer. However, for other stages, females had a greater age difference in survival between middle-aged and older patients with lung cancer than males. Comorbidity and emergency presentation played a minor role. Ethnicity and deprivation did not influence age disparities in lung cancer survival.Conclusion Sex and stage at diagnosis were the most important factors of age disparities in lung cancer survival in New Zealand.What is the key question?How do patient-related and clinical factors influence age pattern in lung cancer survival?What is the bottom line?Age disparities in lung cancer survival were strongest for females and non-advanced disease. Deprivation, ethnicity, comorbidity, and emergency presentation did not influence age disparities.Why read on?Our findings reinforce the call for a better representation of older adults in clinical trials and a wider use of geriatric assessment to identify patients who will benefit treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the European Union Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 842817 to Sophie Pilleron.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Otago Human Ethics Committee (Health) approved the study (Ethics Committee reference number HD19/048).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from New Zealand Ministry of Health (Data-enquiries@health.govt.nz). Restrictions may apply to the availability of these data outside New Zealand. See https://www.health.govt.nz/nz-health-statistics/access-and-use/data-request-form.